Trial News & Events

NEALS Sites Continue to Participate in ALS Ice Bucket Challenge

The ALS Ice Bucket Challenge, started by PALS and Boston native Pete Frates, has been steadily raising awareness for the disease and encouraging donations for ALS research since its inception in the summer of 2014. Over the last few months, participation in the ALS #icebucketchallenge has gone viral on social media. The challenge has seen millions of people dump a bucket of ice water on their head and then nominate three others to either do the same or to donate money to the cause. NEALS and the ALS Multidisciplinary Clinic at Mass General Hospital completed the challenge and nominated three other NEALS sites (Drexel, SUNY Upstate, and Johns Hopkins) to do the same, encouraging those sites to then challenge other NEALS sites. Over 50 NEALS sites around the US and Canada have completed the challenge to date. Please consider a donation to the NEALS Consortium by clicking here.

Medicinova to Initiate Clinical Trial of MN-166

Medicinova, Inc announced the FDA approval to initiate a clinical trial of MN-166 (ibudilast) ALS. The principal investigator of the study is Benjamin Rix Brooks, MD, of Carolinas Neuromuscular/ALS-MDA Center in Charlotte, NC. Read the full press release here.…

2014 Regional CRLI Highlights

The second annual Philadelphia Clinical Research Learning Institute was held May 2nd through the 4th in Philadelphia, PA.